Skip to Main Content
Beta test
our new site.
(
NLM Technical Bulletin
)
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Ketamine Hydrochloride and Best Pain Management in Treating Cancer Patients With Neuropathic Pain
The recruitment status of this study is unknown because the information has not been verified recently.
Verified March 2011
by National Cancer Institute (NCI).
Recruitment status was Recruiting
Study NCT01316744 Information provided by National Cancer Institute (NCI)
First Received on March 15, 2011. Last Updated on May 12, 2011
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Cancer
Additional conditions recognized in this trial
Lymphoma, Large-Cell, Immunoblastic
Lymphoma, Non-Hodgkin
Neuralgia
More general conditions related to this trial
Immune System Diseases
Immunoproliferative Disorders
Lymphatic Diseases
Lymphoma
Lymphoproliferative Disorders
Neoplasms
Neoplasms by Histologic Type
Nervous System Diseases
Neurologic Manifestations
Neuromuscular Diseases
Pain
Peripheral Nervous System Diseases
Signs and Symptoms
Interventions listed in this trial
ketamine hydrochloride
pharmacogenomic studies
questionnaire administration
assessment of therapy complications
quality-of-life assessment
Additional drug interventions recognized in this trial
Ketamine
More general drug interventions related to this trial
Analgesics
Anesthetics
Anesthetics, Dissociative
Anesthetics, General
Anesthetics, Intravenous
Central Nervous System Agents
Central Nervous System Depressants
Excitatory Amino Acid Agents
Excitatory Amino Acid Antagonists
Molecular Mechanisms of Pharmacological Action
Neurotransmitter Agents
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Sensory System Agents
Therapeutic Uses
Sponsors listed in this trial
University of Glasgow
Back to top of Main Content
